Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes
Jp. Celver et al., Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes, J BIOL CHEM, 276(7), 2001, pp. 4894-4900
To determine the sites in the mu -opioid receptor (MOR) critical for agonis
t-dependent desensitization, we constructed and coexpressed MORs lacking po
tential phosphorylation sites along with G-protein activated inwardly recti
fying potassium channels composed of K(ir)3.1 and K(ir)3.4 subunits in Xeno
pus oocytes, Activation of MOR by the stable enkephalin analogue, [D-Ala(2)
,MePhe(4),Glyol(5)]enkephalin, led to homologous MOR desensitization in ooc
ytes coexpressing both G-protein-coupled receptor kinase 3 (GRK3) and beta
-arrestin 2 (arr3), Coexpression with either GRK3 or arr3 individually did
not significantly enhance desensitization of responses evoked by wild type
MOR activation. Mutation of serine or threonine residues to alanines in the
putative third cytoplasmic loop and truncation of the C-terminal tail did
not block GRK/arr3-mediated desensitization of MOR. Instead, alanine substi
tution of a single threonine in the second cytoplasmic loop to produce MOR(
T180A) was sufficient to block homologous desensitization. The insensitivit
y of MOR(T180A) might have resulted either from a block of arrestin activat
ion or arrestin binding to MOR. To distinguish between these alternatives,
we expressed a dominant positive arrestin, arr2(R169E), that desensitizes G
protein-coupled receptors in an agonist-dependent but phosphorylation-inde
pendent manner. arr2(R169E) produced robust desensitization of MOR and MOR(
T180A) in the absence of GRK3 coexpression. These results demonstrate that
the T180A mutation probably blocks GRK3- and arr3-mediated desensitization
of MOR by preventing a critical agonist-dependent receptor phosphorylation
and suggest a novel GRK3 site of regulation not yet described for other G-p
rotein-coupled receptors.